Pharmacotherapy of borderline personality disorder

被引:0
作者
Hirschfeld, RMA [1 ]
机构
[1] Univ Texas, Med Branch, Dept Psychiat & Behav Sci, Galveston, TX 77555 USA
关键词
D O I
暂无
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Borderline personality disorder can be classified into four groups of symptoms: affective, impulsive, ego-interpersonal, and psychotic. Pharmacotherapy of borderline personality disorder should be directed at the severity of the symptoms in each of these groups, rather than by the presence or absence of the overall syndrome. This article reviews the pharmacotherapy of borderline personality disorder, with special emphasis on affective and impulsive symptoms. Overall, the MAOIs, the SSRIs, and the newer antidepressants (such as venlafaxine) provide the widest spectrum of effective treatment for the symptoms of borderline personality disorder.
引用
收藏
页码:48 / 53
页数:6
相关论文
共 19 条
[1]  
CORNELIUS JR, 1991, J CLIN PSYCHOPHARM, V11, P116
[2]  
COWDRY RW, 1988, ARCH GEN PSYCHIAT, V45, P111
[3]  
GARDNER DL, 1986, AM J PSYCHIAT, V143, P519
[4]  
Gunderson JG, 1995, Comprehensive textbook of psychiatry, V2, P1425
[5]  
KAVOUSSI RJ, 1994, J CLIN PSYCHIAT, V55, P137
[6]  
LIEBOWITZ MR, 1988, ARCH GEN PSYCHIAT, V45, P129
[7]  
MARKOVITZ PJ, 1991, AM J PSYCHIAT, V148, P1064
[8]  
MARKOVITZ PJ, 1995, 35 ANN M NEW CLIN DR
[9]   Diagnostic and Statistical Manual of Mental Disorders [J].
Mittal, Vijay A. ;
Walker, Elaine F. .
PSYCHIATRY RESEARCH, 2011, 189 (01) :158-159
[10]   FLUOXETINE IN BORDERLINE PERSONALITY-DISORDER [J].
NORDEN, MJ .
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 1989, 13 (06) :885-893